Table 1 Clinical and biochemical characteristics of the study participants
HF patients with low LVEF | HF patients with normal LVEF | Control subjects | p value | |
|---|---|---|---|---|
(n = 25) | (n = 23) | (n = 21) | ||
Clinical profile | ||||
Male sex, n (%) | 21 (84 %) | 22 (96 %) | 17 (81 %) | 0.31 |
Age (years) | 56.0 ± 7.7 | 56.1 ± 8.7 | 58.9 ± 7.2 | 0.39 |
Height (cm) | 166.8 ± 8.6 | 165.8 ± 7.0 | 164.3 ± 5.0 | 0.48 |
Weight (kg) | 71.6 ± 15.9 | 72.5 ± 12.0 | 70.9 ± 10.4 | 0.92 |
BMI (kg/m2) | 25.5 ± 4.3 | 26.4 ± 4.1 | 26.3 ± 4.0 | 0.75 |
SBP (mmHg) | 127.0 ± 25.4* | 134.0 ± 18.6 | 145.7 ± 7.0 | 0.03 |
DBP (mmHg) | 74.3 ± 10.8* | 73.7 ± 9.4 * | 83.7 ± 12.5 | 0.01 |
Biochemical profile | ||||
Triglyceride (mg/dL) | 150.4 ± 60.3 | 168.5 ± 98.2 | 179.1 ± 4.8 | 0.65 |
Total cholesterol (mg/dL) | 189.8 ± 34.3 | 180.6 ± 31.7 | 178.4 ± 0.0 | 0.70 |
LDL (mg/dL) | 115.5 ± 35 | 108.2 ± 29.7 | 95.1 ± 50.2 | 0.39 |
VLDL (mg/dL) | 29.7 ± 12.6 | 33.8 ± 19.6 | 31.3 ± 23.3 | 0.74 |
HDL (mg/dL) | 45.4 ± 10.1 | 38.6 ± 8.4 | 45.9 ± 25.6 | 0.14 |
T-cho/HDL | 4.4 ± 1.3 | 4.9 ± 1.3 * | 3.2 ± 2.0 | 0.04 |
LDL/HDL | 2.7 ± 1.1 | 2.9 ± 1.1 | 3.3 ± 3.7 | 0.74 |
Non-HDL (mg/dL) | 144.4 ± 37.3 | 142.0 ± 30.3 | 116.2 ± 3.9 | 0.27 |
Fasting glucose (mg/dL) | 121.2 ± 38.1 | 113.4 ± 77.1 | 93 ± 41.3 | 0.52 |
HbA1c (mg/dL) | 6.4 ± 1.2 | 6.5 ± 1.5 * | 4.1 ± 2.7 | 0.03 |